MDMA research in 2026 continues to evolve amid promising results and regulatory challenges. Once primarily known as a recreational substance, 3,4-methylenedioxymethamphetamine (MDMA) is now at the forefront of psychedelic-assisted therapy investigations for conditions like post-traumatic stress disorder (PTSD), anxiety, and depression. This comprehensive guide examines the latest studies, mechanisms, potential benefits, risks, and global developments […]